Columbia’s pediatric hematology/oncology/stem cell transplantation team is launching a groundbreaking program in pediatric neuro-oncology, the Brain Tumor Technology Research (BTTR) initiative.
Through new research studies Dr. Stergios Zacharoulis hopes to impact the currently dismal outlook for the 4,000 children in the US diagnosed each year with a brain or spinal cord tumor.